Note: This story was updated Aug. 25, 2020, to clarify that, according to NuvoAir, the regulatory entity in question is…
Articles by Joana Carvalho, PhD
The U.S. Food and Drug Administration (FDA) has granted the designation of orphan drug to KB407,…
MS1819, AzurRx BioPharma’s investigational treatment for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF), safely…
Scientists have discovered that Vav3, a protein that is over-produced in the lining of the lungs of people with…
Among women of childbearing age with cystic fibrosis (CF), the use of combined hormonal contraceptives containing both estrogen…
After being given more than $3 million from the Cystic Fibrosis Foundation (CFF) in 2017 to expand the…
MyCyFAPP, a mobile app designed to help patients with cystic fibrosis (CF) manage their pancreatic enzyme replacement…
The nonprofit group OneLegacy has launched a video series, available on its social media channels, to raise awareness of the…
Calithera Biosciences announced plans to open by September a first clinical study of its oral investigational therapy CB-280 in…
AzurRx BioPharma has been authorized to conduct its Phase 2b OPTION 2 clinical trial evaluating MS1819, its investigative therapy…